Affinia Therapeutics
Develops transformative gene therapies for devastating diseases using rationally designed AAV vectors.
Develops transformative gene therapies for devastating diseases using rationally designed AAV vectors.
Sector
Life SciencesCategory
AITherapeutics
Location
Waltham, MAInitial Investment
2019Affinia Therapeutics is a gene therapy company with a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies and a mission to develop transformative medicines for devastating diseases.